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Purpose: The aim of this study was to evaluate 3.5 years-cumulative survival rate of implants placed on augmented sinus us-
ing Osteon, a bone graft material, and to assess the height of the grafted material through radiographic evaluation. 
Methods: Twenty patients were treated with maxillary sinus augmentation and 45 implant fixtures were installed simultane-
ously or after 6 months healing period. The height of the augmented sinus and the loss of marginal bone were measured by 
panoramic and intraoral radiographs immediately after augmentation and up to 42 months (mean, 19.4 months) subsequent-
ly. Changes in the height of the sinus graft material were calculated radiographically. 
Results: The cumulative survival rate was 95.56% in all 45 implants. Additionally, normal healing process without any compli-
cation was observed in all patients. The original sinus height was mean 4.3 mm and the augmented sinus height was mean 
13.4 mm after the surgery. The mean marginal bone loss till 42 months was 0.52±0.56 mm. The reduced height of Osteon was 
0.83±0.38 mm and it did not show significant correlation with the follow up periods (P=0.102). There were no statistically sig-
nificant differences in reduced height of Osteon according to the simultaneous/delayed implantation (P=0.299) and particle 
size of Osteon (P=0.644). 
Conclusions:  It can be suggested that Osteon may have predictable result when it was used as a grafting material for sinus 
floor augmentation.
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Case Report
INTRODUCTION
One of the necessary requirements for a dental implant is 
the presence of at least a moderate amount of bone in order 
to place an implant with the appropriate length and diame-
ter. The loss of the alveolar ridge due to trauma, periodontal 
disease, or the failure of endodontic treatment, however, may 
make it difficult to place the implant in the best location for 
proper esthetics and function. The maxillary posterior area, is 
known to be especially difficult for implant treatment and to 
have a low success rate because of the poor bone quality. 
Moreover, the posterior edentulous maxilla has represented 
a challenge for clinicians owing to the resorption of the alve-
olar ridge and pneumatization of the maxillary sinus.
This has led to the development of a bone augmentation 
technique, the onlay bone graft and sinus augmentation. Si-
nus augmentation via lateral window osteotomy has been 
routinely performed in the last few years and has been re-
garded as a predictable procedure [1-4]. However, the choice 
of the bone graft material is still under discussion. 
The use of autogenous bone in sinus augmentation has 
been regarded as a superior method because of the repro-
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ducible healing mechanism of osteogenesis, osteoinduction, 
and osteoconduction. Nevertheless, there are some limita-
tions, e.g., the need for additional surgical sites and the rapid 
resorption rate when the autogenous bone is used as a sinus 
grafting material [5-7]. Therefore, the use of synthetic bone 
has been recently appraised for its biocompatibility and vol-
ume maintenance capacity [8,9].
Various synthetic materials have been developed for use in 
maxillary sinus augmentation to allow bone ingrowth and to 
prevent sinus pneumatization after grafting. Among them, the 
mixture of hydroxiapitite (HA) and beta-tricalcium phosphate 
(β-TCP) has been studied extensively as a new alloplastic ma-
terial [10]. HA can play an osteoconductive role due to its ap-
propriate space maintenance capacity, but it has a low-grade 
osteogenetic property. On the other hand, β-TCP, with its 
good biocompatibility, has been used as a substitute for au-
togenous bone [11,12]. In light of this, mixing adequate ratios 
of HA and β-TCP allows for controlling the resorption rate 
without distorting its the bone’s osteoconductive property 
[13-15]. 
Osteon (Dentium, Seoul, Korea) is synthetic material con-
taining 70% HA and 30% β-TCP. It has a porous structure, 
which can accelerate new bone ingrowth and maturation 
(Fig. 1). Two different particle sizes of Osteon have been used 
(0.5-1.0 mm and 1.0-2.0 mm). In several previous studies, Os-
teon was regarded as a suitable sinus augmentation material 
based on histologic analysis [16]. Moreover, we have previ-
ously reported on the volume maintenance of grafted Oste-
on and implant success rate in a pilot study [17]. In that study, 
the grafted material was well maintained in the sinus and 
decreased slightly over 1 year (0.05 mm/month). It is sug-
gested that Osteon may produce predictable results when it 
is used as a grafting material for sinus floor augmentation.
The aim of the present study was to evaluate the cumula-
tive survival rate (CSR) of implants placed in sinuses aug-
mented with Osteon, and to assess the resorption rate of the 
grafted material radiographically with increased sample size 
and statistical power as an extension to our previous studies.
CASE DESCRIPTION
This study was approved by the Institutional Review Board 
of Yonsei University College of Dentistry (Approval No. 
5-2008-3). A total 45 implants were placed in 20 maxillary si-
nuses of 20 patients (8 males, 12 females, mean age 57.2±11.3 
years) with the condition of having under 5 mm of residual 
alveolar bone height, using a sinus augmentation technique 
via lateral window osteotomy [18]. All implants were main-
tained with at least 6 months of prosthetic loading time. Pa-
tients’ exclusion criteria were: 1) heavy smoking (more than 
20 cigarettes per day), 2) a debilitating systemic disease such 
as uncontrolled diabetes mellitus 3) signs and symptoms of 
maxillary sinus disease, or 4) active periodontal disease in-
volving the residual dentition.
Five implants were from Branemark System-MKIII TiUnite 
(NobelBiocare AB, Gotenborg, Sweden); 12 implants were 
from Xive (Dentsply Friadent, Mannheim, Germany), 5 im-
plants were from Astra (Astra Tech AB, Mölndal, Sweden), 6 
implants were from Osstem GSII (Osstem Implant Co., 
Busan, Korea), and 17 implants were from Implantium (Den-
tium). Five implants had a machined surface; 29 implants 
had a sandblasted, large-grid and acid etched surface; and 11 
implants had a resorbable blast media surface. All implants 
were placed in either one- or two-stage surgery. The timing 
of implantation was determined, depending on the primary 
stabilization of implants. In the two-stage approach, implan-
tation was performed 6 months after the augmentation of 
the maxillary sinus.
A mixture of 2 different types of Osteon in a 1:1 ratio was 
used in 10 patients, while only the larger particle size of Os-
teon was used in the other 10 patients. The quality of bone 
was evaluated according to Lekholm and Zarb’s classification 
during the surgical procedure [19]. Most of the examined 
subsinus ridges were composed of bone with poor quality 
(type III and IV). General information on each case is pre-
sented in Table 1.
Surgical technique
A modified Caldwell-Luc sinus augmentation was per-
formed under local anesthesia (2% lidocaine hydrochloride–
epinephrine 1:100,000; Huons Co., Seoul, Korea) [20,21]. In 
brief, the surgical area was prepared via elevation of a full  Figure 1. Scanning electron microscope image of Osteon.
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Table 1. Case summary.
Case Age/ Sex Area System Diameter Length 1 or 2 stage Original bone 
height (mm)
Dose of 
Osteon (mL)
Type of 
Osteon
Bone quality F/U (mo)
1 54/F 15 Branemark 4 10.5 simultaneous 4.3  3 S/L IV 30
16 Branemark 5 11.5 simultaneous 2.5  IV 30
2 75/F 15 Branemark 4 11.5 simultaneous 5.0  2.5 S/L III 42
16 Branemark 4 11.5 Delayed 2.9  IV 29
17 Branemark 4 11.5 Delayed 3.5  IV 29
3 71/M 26 Implantium 3.8 10 Delayed 5.7  2 S/L III 16
27 Implantium 3.8 10 Delayed 2.5  IV 16
4 64/F 25 Xive 3.4 9.5 Simultaneous 5.5  1.5 S III 18
27 Xive 3.8 9.5 Simultaneous 3.2  IV 18
5 47/F 15 Xive 3.8 9.5 Simultaneous 5.6  1.5 S III 29
16 Xive 4.5 9.5 Simultaneous 5.5  III 29
17 Xive 4.5 9.5 Simultaneous 3.3  III 29
6 54/M 16 Implantium 4.3 8 Simultaneous 5.0  2.5 S/L III 19
17 Implantium 4.3 8 Simultaneous 3.5  III 19
7 59/M 26 Implantium 4.8 12 Simultaneous 4.8  III 17
27 Implantium 4.8 10 Simultaneous 4.9  III 17
8 47/F 25 Astra 4 9 Simultaneous 5.8  2 S/L III 18
26 Astra 4 9 Simultaneous 4.3  IV 18
27 Astra 4 9 Simultaneous 5.4  IV 18
9 70/M 25 Osstem GSII 4 11.5 Simultaneous 5.6  1.5 S/L III 21
26 Osstem GSII 4 8.5 Simultaneous 4.0  III 21
27 Osstem GSII 4 8.5 Simultaneous 4.7  III 21
10 77/F 15 Xive 3.4 9.5 Simultaneous 4.5  3 S III 24
16 Xive 3.4 9.5 Simultaneous 3.5  III 24
11 52/F 26 Xive 3.8 9.5 Delayed 3.8  1.5 S III 18
12 52/F 26 Implantium 4.8 10 Delayed 3.2  1.5 S/L III 15
27 Implantium 4.3 10 Delayed 3.4  III 15
13 55/M 15 Osstem GSII 4 10 Simultaneous 4.8  1.5 S III 20
16 Osstem GSII 4 10 Simultaneous 3.7  III 20
17 Osstem GSII 4.5 10 Simultaneous 3.6  III 20
14 41/M 16 Xive 3.8 9.5 Simultaneous 3.8  2 S III 24
17 Xive 3.8 9.5 Simultaneous 5.1  III 24
15 40/M 16 Astra 4 13 Delayed 4.7  2.5 S/L III 17
17 Astra 4 13 Delayed 5.7  III 17
16 45/F 16 Implantium 4.3 10 Delayed 2.5  2.5 S II 12
17 Implantium 4.3 10 Delayed 3.7  II 12
17 58/M 25 Implantium 4.3 8 Simultaneous 4.3  1.5 S IV 12
26 Implantium 4.3 8 Simultaneous 4.1  IV 12
18 74/F 25 Implantium 3.8 8 Simultaneous 5.4  1.5 S III 12
26 Implantium 4.3 8 Simultaneous 3.2  III 12
27 Implantium 3.8 8 Simultaneous 5.6  III 12
19 53/F 16 Xive 4.5 9.5 Simultaneous 3.7  4 S III 12
17 Xive 4.5 9.5 Simultaneous 3.6  III 12
20 56/F 25 Implantium 4.3 10 Simultaneous 4.4  2.5 S II 12
26 Implantium 4.3 10 Simultaneous 3.8  II 12
S: small particle, L: large particle, F/U: follow up.Journal of Periodontal
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thickness muco-periosteal flap. Osteotomy was performed at 
the lateral surface of the sinus wall using a diamond round 
bur and piezoelectric device (Piezosurgery, Mectron Spa, 
Carasco Genova, Italy) and the sinus membrane was carefully 
lifted. The sinus cavity was then packed with Osteon, and the 
lateral window was covered by an absorbable sponge (Collat-
ape, Zimmer Dental, Calsbad, CA, USA). The muco-periosteal 
flap was repositioned and sutured with absorbable suture 
material (Monosyn 4.0 Glyconate Monofilament, B. Braun 
Melsungen AG, Melsungen, Germany; Vicryl 5.0 Polylactim, 
Johnson & Johnson, New Brunswick, NJ, USA). The prosth-
odontic procedure was completed after a mean healing peri-
od of 6-12 months.
Implant survival rate
The 42 months cumulative survival rate for implants was 
evaluated using life table analysis [22]. The success criteria for 
implants presented by Buser et al. [23] was used.
Radiographic analysis
The radiographic analysis was performed by panoramic ra-
diographs and intraoral radiographs using software (Starpacs, 
Infinitt Co., Seoul, Korea). All the values were calibrated pre-
cisely based on the length of the implant fixture, and these 
were double checked by a single investigator. At least 2 con-
secutive panoramic radiographs were taken--one immedi-
ately after the sinus augmentation, the other 1 year after the 
surgery. Additional radiographs were obtained every 6 to 12 
months through the follow-up period. The linear measure-
ments taken from radiographs were described below (Fig. 2).
The original alveolar bone heights prior to the surgery [24], 
from the alveolar crest to the base of the sinus were measured 
(Table 1). The augmented sinus heights (ASH) were measured 
from the 1st bone to implant contact points to the base of the 
maxillary sinus, which was elevated with Osteon at the mesi-
al and distal aspects of the implants. The volume of marginal 
bone loss (MBL) was obtained compared with the intraoral 
radiographs immediately taken after the surgery and 1 year 
postoperatively. The reduced height of Osteon (RHO) was 
calculated based on the changes in the ASH and MBL.
Statistical analysis
The individual mean values were calculated. Differences in 
RHO according to the timing of implantation and the type 
of Osteon were analyzed using a independent t-test. A one 
way analysis of variance was used to evaluate the difference 
in RHO according to the implant sites. A post-hoc Scheffe 
test was used to evaluate the differences between groups. A P 
value of <0.05 was considered significant. Correlation be-
tween the RHO and follow-up period were determined by 
Spearman’s test. SPSS ver. 12.0.0 (SPSS Inc., Chicago, IL, USA) 
was used for all of the statistical analyses.
Implant survival rate
No complications, including wound dehiscence and sinus 
membrane perforation, were observed in any of the patients. 
Two of the 45 implants were removed between implantation 
and the follow up period (case 2, I16, 17). All loss of implants oc-
curred prior to prosthetic loading. Both cases were successful-
ly restored by wider diameter implants. The 0 to 6 month CSR 
was 95.56%, and this value continues to 42 months (Table 2).
Radiographic results
The mean follow up period for implants after the sinus 
augmentation was 19.4 months (range, 12 to 42 months). The 
original sinus height was a mean of 4.3 mm (range, 2.5 to 5.8 
mm) and the augmented sinus height was a mean of 13.4 mm 
(range, 9.81 to 18.1 mm) after the surgery. The mean crown/
Implant ratio was 1.19±0.24 mm which was relatively higher 
than the natural molar. The marginal bone loss up to 12 
A B
Figure 2. Schematic drawing illustrating the linear measurements 
taken from radiographs. (A) Immediately after the sinus augmenta-
tion. (B) 1-year after the sinus augmentation. ASH (m): mesial aug-
mented sinus height, ASH (d): distal augmented sinus height, OAH 
(m): mesial original alveolar bone height, OAH (d): distal original al-
veolar bone height, MBL: marginal bone loss, I: implant fixture 
length, C: crown length.
Table 2. Life table analysis.
Time (mo) Implant at risk
Failure during 
interval
Interval 
survival (%)
CSR (%)
0-6 45 2 95.56 95.56
7-12 43 0 100 95.56
13-18 32 0 100 95.56
19-24 18 0 100 95.56
25-30 6 0 100 95.56
31-36 1 0 100 95.56
37-42 1 0 100 95.56
CSR: cumulative survival rate.Journal of Periodontal
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months was measured as 0.29±0.42 mm and up to 42 months 
as 0.52±0.56 mm. The RHO 1 year postoperatively was 0.83± 
0.38 mm, and at 42 months postoperatively was 0.88±0.39 mm 
(Table 3). No significant correlation was noted between the 
RHO and follow up periods by Spearman’s test (P=0.102). 
There were no statistically significant differences in the re-
duced height of Osteon depnding on simultaneous or de-
layed implantation (P=0.299; Table 4) and particle size of the 
Osteon (P=0.644; Table 5). In addition, no significant differ-
ence in the RHO was observed according to the site of im-
plantation (P=0.527; Table 6).
DISCUSSION
An ideal material for maxillary sinus augmentation should 
provide biocompatibility to allow bone ingrowth and have a 
space maintaining property to prevent sinus pneumatization 
[24]. In the results of the present study, the grafted Osteon 
was well maintained in the sinus and decreased slightly over 
a 3.5-year time period, demonstrating that it is a clinically 
suitable material for sinus augmentation. 
Some volumetric loss of grafted material is unavoidable 
because of the air pressure from respiration in the maxillary 
sinus regardless of the type of material used [2,25,26]. There-
fore, the change in the height of the grafted material is an 
important factor for implant stability. 
Previous studies about the loss of grafted material have been 
mixed. Hatano et al. [27] used autogenous bone and xenoge-
nous bone mixed at a ratio of 2:1 for sinus augmentation with 
simultaneous implant placement and evaluated the resorp-
tion rate. They reported that statistically significant resorp-
tion had occurred after 2-3 years, and the maxillary sinus floor 
was observed at a similar level or slightly below that of the 
implant apex. On the other hand, Maiorana et al. [28] evalu-
ated the resorption rate after 4 years of maxillary sinus aug-
mentation using synthetic bone graft material (hydroxyapa-
tite and collagen). The survival of implants was 97% and the 
grafted material remained steady, showing a 0.5-1 mm re-
sorption height. Generally, it was reported that the resorption 
rate is influenced by the type of graft material [2]. The resorp-
tion rate was 1.76 mm in autograft, 2.09 mm in allograft 
(freeze-dried demineralized bone), and 0.96 mm in alloplast 
(hydroxyapitite).
The maxillary sinus cavity is a kind of contained defect sur-
rounded by sinus basal bone and the Schneiderian mem-
brane; thus it has excellent healing potential even without 
bone graft materials. From this perspective, the long-lasting 
synthetic and xenogenic bone materials are considered to be 
a better choice in terms of material resorption.
Two out of 45 implants were removed in this study before 
prosthetic loading, so this can be regarded as an early failure. 
It seems that excessive hematoma causes the formation of 
exuberant granulation tissue, which can be detrimental to 
initial osseointegration. The overall CSR was 95.56%, and this 
result was comparable with other studies despite the small 
sample size [1-4].
The reduction in volume of the Osteon was higher than in 
our previous report (0.48 mm resorption in 13 months) [17]. 
No significant difference in the reduced volume of the Oste-
on was observed according to the timing of implantation. 
From our previous studies, it was reported that the largest 
amount of Osteon resorption occurred in the 1st molar area 
and the augmented sinus membrane was changed from a 
convex shape to a flat shape. In this study, however, there was 
no correlation between the area of the implantation and the 
resorption rate.
 Interestingly, the resorption of Osteon occurred regardless 
of the flow of time. In most other papers, it was found that 
the graft materials might undergo gradual resorption and 
pneumatization by time [2,27]. Hieu et al. [29] radiographical-
ly evaluated the changes in height of the xenogenic materials 
(Bio-Oss, Geistlich Sons, Wolhusen, Switzerland; OCS-B, Ni-
Table 3. Radiographic analysis (mean±SD).
C/I ratio
MBL (mm) RHO (mm)
Time (mo) Time (mo)
0-12 0-42 0-12 0-42
Mean 1.19±0.24 0.29±0.42 0.52±0.56 0.83±0.38 0.88±0.39
C/I ratio: crown/implant ratio, MBL: marginal bone loss, RHO: reduced height of 
Osteon.
Table 4. Differences according to the timing of implantation 
(mean±SD).
Simultaneous (n=34) Delayed (n=11) P-value (<0.05)
RHO (mm) 0.80±0.40 0.91±0.30 0.299
RHO: reduced height of Osteon.
Table 5. Differences according to the type of material (mean±SD).
S (n=22) S/L (n=23) P-value (<0.05)
RHO (mm) 0.81±0.43 0.85±0.33 0.644
S: small particle size (0.5-1 mm), L: large particle size (1-2 mm), RHO: reduced 
height of Osteon. 
Table 6. Differences according to the site of implants (mean±SD).
P2 (n=8) M1 (n=22) M2 (n=15) P-value (<0.05)
RHO (mm) 0.92±0.42 0.85±0.34 0.75±0.42 0.527
P2: the 2nd premolar, M1: the 1st molar, M2: the 2nd molar, RHO: reduced height 
of Osteon.Journal of Periodontal
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bec, Seoul, Korea) after maxillary sinus augmentation over 
the course of 2 years. This study reported that significant ma-
terial resorption can take place over time. Nonetheless, it 
could be assumed that many other factors, e.g., the air pres-
sure in the maxillary sinus, the form of augmented material, 
and the density of the grafted material, are more important 
than the time flow. Therefore, it is possible that the resorp-
tion rate of the grafted material is affected by the host’s envi-
ronment. This would be expected to be clarified with further 
study.
Two dimensional panoramic radiographs have been used 
to evaluate the grafted material and its relationship with im-
plants [27,30,31]. Recently, a study utilizing computed-tomog-
raphy and magnetic resonance imaging assessed the grafted 
sinus floor and this showed more accurate results on the vol-
umetric change [32]. However, in the present study, we used 
only 2-dimensional images; thus further study using 3-di-
mensional images would provide a more accurate volumet-
ric measurement of Osteon.
Within the limitations of this study, it can be suggested that 
Osteon may have predictable results when it was used as a 
grafting material for sinus floor augmentation due to its ex-
cellent osteoconductive property.
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